Biocartis Group (Belgium) Analysis
| BCART Stock | EUR 0.29 0.00 0.00% |
Biocartis Group NV is overvalued with Real Value of 0.24 and Hype Value of 0.29. The main objective of Biocartis Group stock analysis is to determine its intrinsic value, which is an estimate of what Biocartis Group NV is worth, separate from its market price. There are two main types of Biocartis Group's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biocartis Group's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biocartis Group's stock to identify patterns and trends that may indicate its future price movements.
The Biocartis Group stock is traded in Belgium on Euronext Brussels, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Belgium. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biocartis Group's ongoing operational relationships across important fundamental and technical indicators.
Biocartis |
Biocartis Stock Analysis Notes
About 28.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.24. Biocartis Group NV had not issued any dividends in recent years. The entity had 783:683 split on the 17th of November 2022. Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people. For more info on Biocartis Group NV please contact Herman Verrelst at 32 1 563 20 00 or go to https://www.biocartis.com.Biocartis Group NV Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biocartis Group's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biocartis Group NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Biocartis Group NV generated a negative expected return over the last 90 days | |
| Biocartis Group NV has some characteristics of a very speculative penny stock | |
| Biocartis Group NV has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 48.27 M. Net Loss for the year was (71.47 M) with loss before overhead, payroll, taxes, and interest of (25.72 M). | |
| Biocartis Group NV has accumulated about 53.52 M in cash with (65.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Biocartis Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biocartis Group's market, we take the total number of its shares issued and multiply it by Biocartis Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biocartis Profitablity
Biocartis Group's profitability indicators refer to fundamental financial ratios that showcase Biocartis Group's ability to generate income relative to its revenue or operating costs. If, let's say, Biocartis Group is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biocartis Group's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biocartis Group's profitability requires more research than a typical breakdown of Biocartis Group's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.85) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.85. Technical Drivers
Biocartis Group NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biocartis Group NV Price Movement Analysis
The output start index for this execution was fifty-nine with a total number of output elements of two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biocartis Group middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biocartis Group NV. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biocartis Group Outstanding Bonds
Biocartis Group issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biocartis Group NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biocartis bonds can be classified according to their maturity, which is the date when Biocartis Group NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
About Biocartis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biocartis Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biocartis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biocartis Group. By using and applying Biocartis Stock analysis, traders can create a robust methodology for identifying Biocartis entry and exit points for their positions.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biocartis Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Complementary Tools for Biocartis Stock analysis
When running Biocartis Group's price analysis, check to measure Biocartis Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocartis Group is operating at the current time. Most of Biocartis Group's value examination focuses on studying past and present price action to predict the probability of Biocartis Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocartis Group's price. Additionally, you may evaluate how the addition of Biocartis Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |